VANCOUVER, Feb. 27 /CNW/ - iCo Therapeutics Inc. (TSX-V: ICO) announced today that Dr. Peter Hnik, iCo’s Chief Medical Officer, has been invited to give a presentation discussing iCo-007 at the 7th International Symposium on Ocular Pharmacology and Therapeutics (ISOPT) in Budapest, Hungary (http://www.kenes.com/isopt/). Dr. Hnik’s presentation, entitled, “iCo-007, a VEGF "+" Agent, for the Potential Treatment of Diabetic Macular Edema and Diabetic Retinopathy”, will take place on March 2nd, 2008.
